User profiles for SINEAD HARNEY

S Harney

Verified email at hse.ie
Cited by 1317

Dissection of class III major histocompatibility complex haplotypes associated with rheumatoid arthritis

JL Newton, SMJ Harney, AE Timms… - … : Official Journal of …, 2004 - Wiley Online Library
Objective We have previously identified a single‐nucleotide polymorphism (SNP) haplotype
involving the lymphotoxin α (LTA) and tumor necrosis factor (TNF) loci (termed haplotype …

Biomarkers to identify ILD and predict lung function decline in scleroderma lung disease or idiopathic pulmonary fibrosis.

…, TM O'Connor, K O'Regan, S Harney… - … Vasculitis, and Diffuse …, 2015 - europepmc.org
Background SSc-ILD and IPF demonstrate significant morbidity and mortality. Predicting
disease progression is challenging in both diseases. Objectives We sought a serum biomarker …

The uptake of influenza and pneumococcal vaccination among immunocompromised patients attending rheumatology outpatient clinics

M Haroon, F Adeeb, A Eltahir, S Harney - Joint Bone Spine, 2011 - Elsevier
PURPOSE AND OBJECTIVES: The patients using immunosuppressive agents are
considered at high risk for acquiring different infections. Accordingly, international guidelines …

[HTML][HTML] Effect of a hop extract standardized in 8-prenylnaringenin on bone health and gut microbiome in postmenopausal women with osteopenia: a one-year …

…, D Tomassi, R Rizzoli, M Tenon, T Berton, S Harney… - Nutrients, 2023 - mdpi.com
Estrogen deficiency increases the risk of osteoporosis and fracture. The aim of this study
was to investigate whether a hop extract standardized in 8-prenylnaringenin (8-PN), a potent …

Cogan's syndrome: present and future directions

G Murphy, MO Sullivan, F Shanahan, S Harney… - Rheumatology …, 2009 - Springer
Cogan’s syndrome, typified by the combination of interstitial keratitis and immune-mediated
sensorineural hearing loss, is a rare condition, and commonly associated with a diagnostic …

Therapeutics in rheumatology and the kidney

T Harty, M O'Shaughnessy, S Harney - Rheumatology, 2023 - academic.oup.com
The field of rheumatology has advanced significantly in recent years to provide rheumatologists
with an extensive array of medications to combat rheumatic joint conditions. In contrast …

[PDF][PDF] Efficacy and safety of rituximab in connective tissue disease related interstitial lung disease

…, O Cronin, L Harty, S Harney… - … Vasc Diffuse Lung …, 2015 - researchgate.net
Background: Pulmonary complications of connective tissue disease are being identified
more frequently with the advent of more sophisticated radiological investigations. Limited …

Cyclophosphamide-refractory scleroderma-associated interstitial lung disease: remarkable clinical and radiological response to a single course of rituximab combined …

…, P McLaughlin, M Henry, S Harney - … in respiratory disease, 2011 - journals.sagepub.com
We would like to report our experience of using rituximab in cyclophosphamide refractory,
rapidly progressive interstitial lung disease (ILD) in a patient with limited scleroderma. A 40-…

[HTML][HTML] MDA-5 associated rapidly progressive interstitial lung disease with recurrent Pneumothoraces: a case report

S Alqatari, P Riddell, S Harney, M Henry… - BMC Pulmonary …, 2018 - Springer
Background Clinically hypomyopathic dermatomyositis is a rare disease that is important to
recognize, investigate and treat early as it is associated with poor prognosis. In a proportion …

Molecular genetics of rheumatoid arthritis

SMJ Harney, JL Newton, BP Wordsworth - Current opinion in pharmacology, 2003 - Elsevier
Following the successful determination of the molecular genetics of single-gene disorders,
attention has not surprisingly turned to complex genetic disorders. However, preliminary …